Clinical Trials Directory

Trials / Unknown

UnknownNCT05468944

Robotic Transanal Specimen Extraction Surgery Versus Robotic Transabdominal Incision Specimen Extraction Surgery for Patients With Rectal Cancer: A Multicenter Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
556 (estimated)
Sponsor
Taiyuan Li · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This prospective, multicenter, randomized, open-label study aims to evaluate the perioperative safety and feasibility of specimen extraction through anus regarding robotic radical excision of rectal cancer.

Detailed description

In this study, investigators will evaluate the perioperative safety and feasibility of robotic transanal specimen extraction surgery with robotic transabdominal incision specimen extraction surgery as a control.The study is prospective, randomized, open-label, and multicenter conducted at 12 centers. Considering the significance level and abscission rate, it is expected that a total of 556 subjects will be included in the two groups from January 2023 to June 2024, with the incidence of postoperative complications as the main study endpoint.

Conditions

Interventions

TypeNameDescription
PROCEDURETransanal specimen extraction robotic surgeryParticipants in this group underwent robotic rectal cancer resection ,the specimens were extracted through anus.
PROCEDURETransabdominal specimen extraction robotic surgeryParticipants in this group underwent robotic assisted rectal cancer resection ,the specimens were extracted through the incision on the abdominal wall.

Timeline

Start date
2023-01-01
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2022-07-21
Last updated
2022-07-21

Locations

12 sites across 1 country: China

Source: ClinicalTrials.gov record NCT05468944. Inclusion in this directory is not an endorsement.